# Efficacy and Safety of Functional Neurogenesis Stimulation Therapy in Children With Autism Spectrum Disorder (ASD)

> **NCT07276555** · NA · NOT_YET_RECRUITING · sponsor: **Neurocytonix, Inc.** · enrollment: 256 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DEVICE:** Functional Neurogenesis Stimulation Therapy
- **OTHER:** placebo control group

## Key facts

- **NCT ID:** NCT07276555
- **Lead sponsor:** Neurocytonix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2029-02-01
- **Final completion:** 2029-05-29
- **Target enrollment:** 256 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276555, "Efficacy and Safety of Functional Neurogenesis Stimulation Therapy in Children With Autism Spectrum Disorder (ASD)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07276555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*